Diego
Martínez Urbistondo
Colaborador Médico
Universidad CEU San Pablo
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Universidad CEU San Pablo (2)
2023
-
Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution
Frontiers in Immunology, Vol. 14
2022
-
Hematological-and Immunological-Related Biomarkers to Characterize Patients with COVID-19 from Other Viral Respiratory Diseases
Journal of Clinical Medicine, Vol. 11, Núm. 13